39 related articles for article (PubMed ID: 15623750)
1. Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy.
Wagner SN; Wagner C; Schultewolter T; Goos M
Cancer Immunol Immunother; 1997 Jun; 44(4):239-47. PubMed ID: 9222283
[TBL] [Abstract][Full Text] [Related]
2. In vitro differentiation and antigenic changes in human melanoma cell lines.
Guarini L; Temponi M; Edwalds GM; Vita JR; Fisher PB; Ferrone S
Cancer Immunol Immunother; 1989; 30(5):262-8. PubMed ID: 2624919
[TBL] [Abstract][Full Text] [Related]
3. Correlation of PRAME immunohistochemistry with PRAME status on gene expression profiling in enucleated uveal melanoma.
Vizcaino MA; Dalvin LA; Salomao DR
Can J Ophthalmol; 2024 Jun; 59(3):e279-e282. PubMed ID: 38114062
[No Abstract] [Full Text] [Related]
4. Delineating three-dimensional behavior of uveal melanoma cells under anchorage independent or dependent conditions.
Goyeneche AA; Lasiste JME; Abdouh M; Bustamante P; Burnier JV; Burnier MN
Cancer Cell Int; 2024 May; 24(1):180. PubMed ID: 38783299
[TBL] [Abstract][Full Text] [Related]
5. Tumor Pigmentation Does Not Affect Light-Activated Belzupacap Sarotalocan Treatment but Influences Macrophage Polarization in a Murine Melanoma Model.
Ma S; Huis In't Veld RV; Hao Y; Gu Z; Rich C; Gelmi MC; Mulder AA; van Veelen PA; Vu TKH; van Hall T; Ossendorp FA; Jager MJ
Invest Ophthalmol Vis Sci; 2024 Jan; 65(1):42. PubMed ID: 38271187
[TBL] [Abstract][Full Text] [Related]
6. New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma.
Violanti SS; Bononi I; Gallenga CE; Martini F; Tognon M; Perri P
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31109147
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.
Komatsubara KM; Carvajal RD
Curr Oncol Rep; 2017 Jul; 19(7):45. PubMed ID: 28508938
[TBL] [Abstract][Full Text] [Related]
8. Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis).
Jager MJ; Magner JA; Ksander BR; Dubovy SR
Trans Am Ophthalmol Soc; 2016 Aug; 114():T5. PubMed ID: 28018010
[TBL] [Abstract][Full Text] [Related]
9. Genetic and molecular characterization of uveal melanoma cell lines.
Griewank KG; Yu X; Khalili J; Sozen MM; Stempke-Hale K; Bernatchez C; Wardell S; Bastian BC; Woodman SE
Pigment Cell Melanoma Res; 2012 Mar; 25(2):182-7. PubMed ID: 22236444
[TBL] [Abstract][Full Text] [Related]
10. Differential expression patterns of capping protein, protein phosphatase 1, and casein kinase 1 may serve as diagnostic markers for malignant melanoma.
Sun D; Zhou M; Kowolik CM; Trisal V; Huang Q; Kernstine KH; Lian F; Shen B
Melanoma Res; 2011 Aug; 21(4):335-43. PubMed ID: 21566537
[TBL] [Abstract][Full Text] [Related]
11. Activated CD11b+ CD15+ granulocytes increase in the blood of patients with uveal melanoma.
McKenna KC; Beatty KM; Bilonick RA; Schoenfield L; Lathrop KL; Singh AD
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4295-303. PubMed ID: 19369244
[TBL] [Abstract][Full Text] [Related]
12. Isolation, establishment, and characterization of ex vivo equine melanoma cell cultures.
Chapman SW; Metzger N; Grest P; Feige K; von Rechenberg B; Auer JA; Hottiger MO
In Vitro Cell Dev Biol Anim; 2009; 45(3-4):152-62. PubMed ID: 19057970
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
[TBL] [Abstract][Full Text] [Related]
14. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
Ringhoffer M; Schmitt M; Karbach J; Jäger E; Oesch F; Arand M
Int J Oncol; 2001 Nov; 19(5):983-9. PubMed ID: 11604998
[TBL] [Abstract][Full Text] [Related]
16. Human melanoma-associated antigens.
Graf LH; Ferrone S
Immunol Ser; 1989; 43():643-79. PubMed ID: 2490510
[TBL] [Abstract][Full Text] [Related]
17. T-cell recognition of melanoma-associated antigens.
Castelli C; Rivoltini L; Andreola G; Carrabba M; Renkvist N; Parmiani G
J Cell Physiol; 2000 Mar; 182(3):323-31. PubMed ID: 10653598
[TBL] [Abstract][Full Text] [Related]
18. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
van Dinten LC; Pul N; van Nieuwpoort AF; Out CJ; Jager MJ; van den Elsen PJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):24-30. PubMed ID: 15623750
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
